Publications by authors named "A Coll"

Awareness of nutrition's role in chronic diseases is rising, demanding guidance on the diet-disease relationship. Nutritional practices become crucial for prevention, prompting healthcare professionals (HCP) to respond. The present study assessed a Culinary Medicine (CM) program's impact on HCP's Mediterranean diet adherence, food and diet therapy knowledge, food management skills, culinary proficiency, and counseling confidence.

View Article and Find Full Text PDF

Due to its depletion in natural settings, the potential for aquaculture of the cnidarian Anemonia viridis is currently attracting research interest. Knowledge about the physiology of this species is necessary to ensure optimal development of, and well-being in, aquaculture. This study tested the effects of different abiotic (limited sunlight, brackish water) and biotic (integrated multitrophic aquaculture or IMTA) conditions on A.

View Article and Find Full Text PDF

Liver X receptor-α (LXRα) regulates cellular cholesterol abundance and potently activates hepatic lipogenesis. Here we show that at least 1 in 450 people in the UK Biobank carry functionally impaired mutations in LXRα, which is associated with biochemical evidence of hepatic dysfunction. On a western diet, male and female mice homozygous for a dominant negative mutation in LXRα have elevated liver cholesterol, diffuse cholesterol crystal accumulation and develop severe hepatitis and fibrosis, despite reduced liver triglyceride and no steatosis.

View Article and Find Full Text PDF

Aims: Heart failure and associated cachexia is an unresolved and important problem. This study aimed to determine the factors that contribute to cardiac cachexia in a new model of heart failure in mice that lack the integrated stress response (ISR) induced eIF2α phosphatase, PPP1R15A.

Methods And Results: Mice were irradiated and reconstituted with bone marrow cells.

View Article and Find Full Text PDF
Article Synopsis
  • * Out of these patients, 8 experienced treatment intolerance with asciminib while 11 developed resistance; treatment strategies included dose adjustments of cTKIs or considering ponatinib despite previous non-candidacy.
  • * The overall survival rate was 73% with the best outcomes for those intolerant to drugs (100%), while patients who progressed to advanced stages had a notably low survival rate (25%).
View Article and Find Full Text PDF